| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | 5.86e-04 | 279 | 28 | 4 | GO:0005096 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 6.27e-04 | 507 | 28 | 5 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 6.27e-04 | 507 | 28 | 5 | GO:0060589 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 1.36e-03 | 39 | 28 | 2 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 1.81e-03 | 45 | 28 | 2 | GO:0043175 | |
| Domain | DUF4599 | 1.32e-04 | 12 | 27 | 2 | PF15371 | |
| Domain | DUF4599 | 1.32e-04 | 12 | 27 | 2 | IPR027970 | |
| Domain | Channel_four-helix_dom | 3.06e-03 | 57 | 27 | 2 | IPR027359 | |
| Domain | - | 3.06e-03 | 57 | 27 | 2 | 1.20.120.350 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 28789966 | ||
| Pubmed | BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity. | 3.75e-06 | 4 | 28 | 2 | 15644318 | |
| Cytoband | 9q21.32 | 6.09e-05 | 19 | 28 | 2 | 9q21.32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 6.56e-03 | 199 | 28 | 2 | chr9q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p15 | 6.88e-03 | 204 | 28 | 2 | chr5p15 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 4.84e-05 | 198 | 27 | 4 | M7610 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 4.93e-05 | 199 | 27 | 4 | M1746 | |
| Coexpression | GSE7852_TREG_VS_TCONV_UP | 5.03e-05 | 200 | 27 | 4 | M5751 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 5.03e-05 | 200 | 27 | 4 | MM1033 | |
| Coexpression | GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN | 5.03e-05 | 200 | 27 | 4 | M7356 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 7.51e-05 | 437 | 27 | 5 | M1610 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 9.08e-05 | 455 | 27 | 5 | MM1189 | |
| Computational | Neighborhood of GSPT1 | 7.03e-05 | 169 | 15 | 4 | GCM_GSPT1 | |
| Computational | Neighborhood of USP6 | 1.14e-04 | 70 | 15 | 3 | GCM_USP6 | |
| Computational | Neighborhood of NF2 | 6.52e-04 | 302 | 15 | 4 | GCM_NF2 | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.68e-06 | 198 | 26 | 5 | 5501_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 6832_DN | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 4470_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 5325_UP | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 1514_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 7101_UP | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 6082_DN | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 5077_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; HL60; HG-U133A | 6.86e-05 | 196 | 26 | 4 | 1993_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.86e-05 | 196 | 26 | 4 | 1054_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 6455_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; HL60; HG-U133A | 7.00e-05 | 197 | 26 | 4 | 1374_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 5793_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 6523_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 5095_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.28e-05 | 199 | 26 | 4 | 1055_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 2802_DN | |
| Disease | coronary artery disease, factor VII measurement | 3.67e-03 | 111 | 24 | 2 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 3.80e-03 | 113 | 24 | 2 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 3.93e-03 | 115 | 24 | 2 | EFO_0001645, EFO_0004694 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 4.13e-03 | 118 | 24 | 2 | EFO_0001645, EFO_0004629 | |
| Disease | sleep quality | 4.13e-03 | 118 | 24 | 2 | EFO_0005272 | |
| Disease | ascending aortic diameter | 5.76e-03 | 140 | 24 | 2 | EFO_0021787 | |
| Disease | cardiovascular disease | 5.87e-03 | 457 | 24 | 3 | EFO_0000319 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QADHSPSMTATHFPR | 266 | Q6ZT62 | |
| DLNTHFRSQSFHTSM | 256 | Q96CN4 | |
| FTSATHLEHVRPMFK | 936 | Q9Y6D6 | |
| PEFNMAAFTTTLQHH | 86 | Q9Y2Y0 | |
| HPEHQSSDSTFLVFM | 156 | Q6UXS9 | |
| ESRSSIHNFMTHPEF | 1136 | P20020 | |
| TTRRNSEYEHMQHFP | 706 | Q33E94 | |
| RMFPHHSITESVNYD | 66 | Q8WUM0 | |
| FRPHSTDSATHRKMT | 491 | Q8WVC0 | |
| MAFPATSIFHTFSHS | 446 | Q8TDN1 | |
| HIPHMLSFNAAFSQR | 1646 | Q96RV3 | |
| SHIPRQSFNMHDSSS | 501 | Q32MH5 | |
| VPFLMHDEHLSRTTN | 266 | Q9HCC8 | |
| NEHMAPTVRATIAHF | 256 | Q8IZJ4 | |
| PFAHLHHRDSMTTEN | 506 | Q08462 | |
| SMHEPLQNEVFASRH | 681 | Q8TBE0 | |
| HHTFFRMPENESNSL | 291 | Q9HCS5 | |
| VGSRTTHHFMYPESA | 191 | Q16842 | |
| ASSFPRSFHERSSNM | 746 | Q6ZUB0 | |
| FISMTSAAPHFRTRH | 171 | P0DPD7 | |
| TVPSFMEDNSRFSHV | 391 | Q13591 | |
| MYRESENSSFPSHRH | 861 | Q14865 | |
| MSSHHTTFPFDPERR | 1 | O94762 | |
| EHFSPFRVQHMDLSN | 176 | Q13309 | |
| ASSFPRSFHERSSNM | 746 | P0C874 | |
| MSHLHTFRATFQEPL | 411 | Q14142 | |
| IPFSHVSHNDMKTES | 486 | Q5TAH2 | |
| IDNHRMTFHVPFNAT | 211 | Q05996 | |
| LRSEAFFHAMTSQHE | 226 | Q9P1Q0 | |
| MDSFSFLQHPVHQRS | 741 | B2RTY4 |